I saw a posting this week that the Oklahoma Medical Research Foundation is seeking RA patients to participate in several drug studies. Anyone interested in participating may call the Clinical Pharmacy Research Program at 271-7805 or email clinic@omrf.org. No deadline for participation was given in the news alert.
Roche Holdings AG (manufacturer of MabThera® (rituximab) ) announced on July 10 that its new RA drug Actemra has proved successful in a phase III clinical study. The study, called RADIATE (Research on Actemra Determining effIcacy after Anti-Tnf FailurEs) evaluated the effectiveness of the drug in patients whose disease has not responded to at... Read more
I saw an interesting article in the NY Times online on June 26th discussing new study showing that employers who shift too much of prescription drug costs to employees end up losing more money through lost productivity than what they would have spent on the drugs. The three-year study was conducted by the nonprofit Integrated Benefits Institute (a... Read more
Several studies have shown that people with rheumatoid arthritis are both less likely to exercise than the general population and also have a higher risk of cardiovascular problems than the general population. The increased cardiovascular risk could be due in part to the inflammation in the body, but is also compounded by lack of physical... Read more
Anyone who plays sports or exercises regularly knows that it’s important to stretch, warm up and cool down, wear the proper clothes and keep hydrated. It’s also important to have the right gear, especially people with special orthopedic problems, like people with rheumatoid arthritis. It’s important to buy shoes from a store... Read more